Tether have Invested $200 Million in Blackrock Neurotech's Neurological Disorder Solutions
Tether, the issuer of the USDT stablecoin, has made a groundbreaking move in the healthcare sector with a strategic $200 million investment in Blackrock Neurotech, a leading biotech company specializing in brain-computer interface (BCI) technology.
Paolo Ardoino, CEO of Tether, expressed his enthusiasm for the partnership, emphasizing Tether’s commitment to nurturing emerging technologies with transformative capabilities.
Ardoino said,
“Blackrock Neurotech is just the beginning of our journey through Tether Evo to venture into projects that redefine the boundaries of what’s possible at the intersection of technological innovation and human potential.”
Ardoino also highlighted the potential of Blackrock Neurotech’s BCI technology to revolutionize communication, rehabilitation, and cognitive enhancement.
“Tether has long believed in nurturing emerging technologies that have transformative capabilities, and the Brain-Computer-Interfaces of Blackrock Neurotech have the potential to open new realms of communication, rehabilitation, and cognitive enhancement.”
Dr. Florian Solzbacher, co-founder of Blackrock Neurotech, expressed his deep gratitude for Tether’s support. He emphasized the shared long-term vision of both companies to advance healthcare and improve the lives of millions worldwide.
“My life’s dream has been to help and restore function in people who lost it and to advance technologies that revolutionize healthcare and the world around us,” Solzbacher, co-founder of Blackrock Neurotech, said.
Solzbacher added,
“This ambitious, long-term endeavour requires dedicated and visionary partners. With its commitment to seeking out and nurturing technology that will help many people and push mankind forward, we couldn’t dream of a better partner than Tether to bring our shared vision to life.”
Ignore the tags please: